Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (23,999,794)	$ (35,578,067)	$ (32,938,065)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	12,853,148	15,800,554	14,979,398
Amortization of debt issuance costs	926,180	1,278,578	1,499,924
Stock based compensation expense related to issuance of restricted stock	43,700	38,094	25,814
Accretion of preferred equity costs			189,920
Equity in loss of unconsolidated joint venture	2,114,897
Unrealized derivative gain (loss)	377,190	(482,632)	90,825
Derivative fair value adjustment	410,657	1,770,963	2,553,422
Unrealized foreign currency adjustment	(2,175,698)	6,513,187	(528,949)
Changes in operating assets and liabilities:
Other assets, net	1,494,094	530,680	(2,785,513)
Purchase of interest rate derivative	(1,027,741)	(2,913,815)	(3,279,000)
Settlement of interest rate derivative	(2,030,731)
Purchase of foreign exchange derivative			(1,442,000)
Accounts payable and accrued liabilities	537,143	(599,126)	5,138,182
Due to affiliates	(9,308,508)	8,127,545	3,869,115
Net cash used in operating activities	(19,785,463)	(5,514,039)	(12,626,927)
Cash flows from investing activities:
Purchase of real estate facilities			(252,273,853)
Additions to real estate facilities	(12,743,728)	(10,388,088)	(8,078,768)
Deposits on acquisitions of real estate facilities and investments in unconsolidated real estate ventures			(148,220)
Refund of deposits on acquisitions of real estate facilities		481,866
Investment in company owned life insurance	(925,788)	(902,063)	(886,460)
Investments in unconsolidated real estate ventures	(7,425,096)	(17,702,419)	(7,171,769)
Return of capital on investments in unconsolidated real estate ventures		15,988,299
Net cash used in investing activities	(21,094,612)	(12,522,405)	(268,559,070)
Cash flows from financing activities:
Proceeds from issuance of secured debt	178,196,483	8,000,000	179,324,261
Repayment of secured debt	(164,160,942)	(4,764,241)	(50,000,000)
Scheduled principal payments of secured debt	(1,453,106)	(4,160,385)	(862,320)
Prepaid debt issuance costs			(42,000)
Debt issuance costs	(1,825,431)	(480,950)	(1,666,788)
Gross proceeds from issuance of common stock	15,367,193	37,371,916	37,910,737
Offering costs	(2,508,610)	(3,634,282)	(4,387,423)
Proceeds from issuance of preferred equity in our Operating Partnership			15,000,000
Redemption of preferred equity in our Operating Partnership			(15,000,000)
Preferred equity in our Operating Partnership issuance costs			(189,920)
Gross proceeds from issuance of preferred stock			150,000,000
Preferred stock issuance costs			(1,400,277)
Proceeds from issuance of Series C units	659,151	1,220,331	3,197,083
Proceeds from issuance of Series D preferred units	35,000,000
Series D Preferred unit issuance costs	(373,312)
Redemption of common stock	(4,132,001)	(1,860,904)	(419,094)
Distributions paid to common stockholders	(8,598,699)	(7,626,356)	(6,160,627)
Distributions paid to noncontrolling interest in our Operating Partnership	(340,865)	(341,104)	(341,025)
Distributions paid to preferred stockholders	(12,516,374)	(12,530,766)	(5,218,750)
Distributions paid to preferred unitholders in our Operating Partnership	(361,667)		(271,250)
Net cash provided by financing activities	32,951,820	11,193,259	299,472,607
Impact of foreign exchange rate changes on cash and restricted cash	280,852	(1,299,322)	(370,083)
Net change in cash, cash equivalents and restricted cash	(7,647,403)	(8,142,507)	17,916,527
Cash, cash equivalents and restricted cash, beginning of year	17,565,564	25,708,071	7,791,544
Cash, cash equivalents and restricted cash, end of year	9,918,161	17,565,564	25,708,071
Supplemental disclosures and non-cash transactions:
Cash paid for interest, net of amounts capitalized	17,844,314	17,208,371	18,819,476
Distribution of common stock	0		6,586,579
Offering costs included in accounts payable and accrued liabilities	(1,334,105)	588,163	661,400
Interest rate swap contract in other assets	1,302,337	467,719	145,375
Interest rate swap contracts in accounts payable and accrued liabilities	247,942	368,600	170,708
Foreign currency hedge contract in other assets	0	1,281,151
Foreign currency translation adjustment	(2,240,708)	4,808,321	(57,174)
Deposits applied to investments in unconsolidated real estate ventures		328,545
Deposits on acquisition of real estate facilities in due to affiliates			333,495
Issuance of shares pursuant to distribution reinvestment plan	6,666,207	5,736,254	4,391,918
Distributions payable to common and preferred stockholders	4,650,971	4,380,620	4,174,068
Distributions payable to noncontrolling interests in our Operating Partnership	28,964	28,885	28,964
Real estate and construction in process in accounts payable and accrued liabilities	701,112	1,658,865	913,229
Redemption of common stock in accounts payable and accrued liabilities	$ 193,867	$ 442,933	118,691
Unrealized derivative adjustment			576,497
Deposits applied to acquisition of real estate			$ 1,076,020